BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22042012)

  • 21. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients.
    Shields CL; Cater J; Shields JA; Chao A; Krema H; Materin M; Brady LW
    Arch Ophthalmol; 2002 Jul; 120(7):933-40. PubMed ID: 12096964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eye retention after proton beam radiotherapy for uveal melanoma.
    Egger E; Zografos L; Schalenbourg A; Beati D; Böhringer T; Chamot L; Goitein G
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):867-80. PubMed ID: 12605964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
    Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
    Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of enucleation after proton beam irradiation of uveal melanoma.
    Egan KM; Gragoudas ES; Seddon JM; Glynn RJ; Munzenreider JE; Goitein M; Verhey L; Urie M; Koehler A
    Ophthalmology; 1989 Sep; 96(9):1377-82; discussion 1382-3. PubMed ID: 2550868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma.
    Mashayekhi A; Tuncer S; Shields CL; Shields JA
    Eur J Ophthalmol; 2013; 23(3):399-409. PubMed ID: 23483500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Endoresection following proton beam irradiation of large uveal melanomas].
    Bechrakis NE; Höcht S; Martus P; Kreusel KM; Heese J; Foerster MH
    Ophthalmologe; 2004 Apr; 101(4):370-6. PubMed ID: 15067418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
    Verma V; Mehta MP
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
    Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
    Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
    Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
    Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complications after proton beam therapy for uveal malignant melanoma. A clinical and histopathologic study of five cases.
    Kincaid MC; Folberg R; Torczynski E; Zakov ZN; Shore JW; Liu SJ; Planchard TA; Weingeist TA
    Ophthalmology; 1988 Jul; 95(7):982-91. PubMed ID: 2845323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.
    Mantel I; Schalenbourg A; Bergin C; Petrovic A; Weber DC; Zografos L
    Am J Ophthalmol; 2014 Oct; 158(4):693-701.e2. PubMed ID: 25034116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plaque brachytherapy for posterior uveal melanoma in 2018: improved techniques and expanded indications.
    Reichstein D; Karan K
    Curr Opin Ophthalmol; 2018 May; 29(3):191-198. PubMed ID: 29538180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of radiotherapy on uveal melanomas and adjacent tissues.
    Groenewald C; Konstantinidis L; Damato B
    Eye (Lond); 2013 Feb; 27(2):163-71. PubMed ID: 23196647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conservative treatment of uveal melanoma: local recurrence after proton beam therapy.
    Munzenrider JE; Verhey LJ; Gragoudas ES; Seddon JM; Urie M; Gentry R; Birnbaum S; Ruotolo DM; Crowell C; McManus P
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):493-8. PubMed ID: 2550395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic photon beam irradiation of uveal melanoma.
    Zehetmayer M
    Dev Ophthalmol; 2012; 49():58-65. PubMed ID: 22042013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton Beam Irradiation: A Safe Procedure in Postequatorial Extraocular Extension From Uveal Melanoma.
    Seibel I; Riechardt AI; Erb-Eigner K; Böker A; Cordini D; Heufelder J; Joussen AM
    Am J Ophthalmol; 2018 Jul; 191():49-53. PubMed ID: 29655645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.
    Willerding GD; Cordini D; Moser L; Krause L; Foerster MH; Bechrakis NE
    Br J Ophthalmol; 2016 Apr; 100(4):463-7. PubMed ID: 26224096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.